UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | H | L | M | P | S | V | W
Number of items: 14.

A

Al-Mufti, RAM; Pedley, RB; Marshall, RB; Begent, RHJ; Winslet, MCAH; K, EF; (1996) In vitro assessment of Lipiodol targeted radiotherapy for primary and metastatic liver cancers. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 20 - ?).

Anlezark, GM; Cook, R; Melton, RG; Freemantle, P; Pedley, RB; Boden, J; Knox, RJ; (1996) Biodistribution of A5B7 F(ab')2: E coli B nitroreductase conjugate in nude mice with human xenografts. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 40 - ?).

B

Begent, RHJ; Chester, KA; (1996) Single chain Fv antibodies for targeting cancer therapy. In: Immunology. (pp. SI113 - SI113).

C

Chester, KA; Hawkins, RE; (1996) Opportunities with phage technology and antibody engineering of fusion proteins. Advanced Drug Delivery Reviews , 22 (3) 303 - 313.

H

Hawkins, RE; Chester, KA; (1996) Applications of antibody gene technology. In: Dalgleish, AG and Browning, MJ, (eds.) Tumour Immunology. Cambridge University Press

L

Lee, SM; Portmann, B; Margison, GP; (1996) Abnormal intracellular distribution of 06-alkylguanine-DNA-alkyltransferase in hepatitis B cirrhotic human liver: A potential cofactor in the development of hepatocellular carcinoma. Hepatology , 24 (5) 987 - 990.

Lee, SM; Portmann, B; Margison, GP; (1996) Abnormal intracellular distribution of 06-alkylguanine-DNA-alkyltransferase in hepatitis-B cirrhotic human liver: a potential cofactor in the development of hepatocellular carcinoma. In: Paterson Annual Research Report. (pp. 24 - ?).

Lee, SM; Radford, JA; Ryder, WDJ; Crowther, D; (1996) Prognostic factors for disease progression in advanced Hodgkin's disease. In: (Proceedings) VIth International Conference on Malignant Lymphoma, Lugano.. (pp. 52 - ?). Annals of Oncology

M

Margison, GP; Rafferty, JA; Elder, RH; Kelly, J; Watson, AJ; Willington, MA; ... McElhinney, RS; + view all (1996) Modulating nitrosourea response in tumors and normal tissue: application to fotemustine. Drugs of Today , 32 (Jan) 51 - 59.

Marshall, D; Pedley, RB; Boden, J; Boden, R; Melton, RGAB; R, HJ; (1996) Effect of polyethylene glycol modification of a galactosylated streptavidin clearing agent on immunogenicity and clearance of a biotinylated anti-tumour antibody. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 71 - ?).

P

Pedley, RB; Boden, J; Boden, R; Boxer, GM; and Begent, RHJ; (1996) Enhancement of radioimmunotherapy by tumour blood flow modifying agents. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 70 - ?).

S

Short, S; Chatterverdi, A; Leslie, M; (1996) The treatment of adrenal metastases. Clinical Oncology , 8 387 - 389.

V

Verhaar, MJ; Keep, PA; Hawkins, RE; Robson, L; Casey, JL; Pedley, B; ... Chester, KA; + view all (1996) Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine. Journal of Nuclear Medicine , 37 (5) 868 - 872.

W

Woll, PJ; Lee, SM; Lomax, L; Hodgetts, J; Stout, R; Burn, PA; ... Thatcher, N; + view all (1996) Randomised phase II study of standard versus dose-intensive ICE chemotherapy with reinfusion of haemopoietic progenitors in whole blood in small cell lung cancer (SCLC). In: (Proceedings) Oral presentation. 1996 ASCO Annual Meeting, Philadelphia, Pennsylvania.. (pp. 333 - ?). Proceedings of the American Society of Clinical Oncology

This list was generated on Sun May 17 03:49:08 2015 BST.